Oxymorphone: a review

Abstract

Oxymorphone (oxymorphone hydrochloride) (14-hydroxy-dihydromorphinone), a semisynthetic μ-opioid agonist, was first approved by the US Food and Drug Administration in 1959. Oxymorphone is considered a more potent opioid than its parent compound, morphine. Recently, an immediate-release and long-acting oral formulation of this drug was developed that makes oxymorphone a new option in treating moderate to severe pain. This article reviews the pharmacodynamics, pharmacology, and clinical efficacy for this new option in treating moderate to severe pain.

DOI: 10.1007/s00520-005-0917-1

2 Figures and Tables

010020020072008200920102011201220132014201520162017
Citations per Year

373 Citations

Semantic Scholar estimates that this publication has 373 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Prommer2005OxymorphoneAR, title={Oxymorphone: a review}, author={Eric E. Prommer}, journal={Supportive Care in Cancer}, year={2005}, volume={14}, pages={109-115} }